The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gromova O.A.

Federal Research Center «Computer Science and Control»

Torshin I.Yu.

Federal Research Center «Computer Science and Control»

Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules

Authors:

Gromova O.A., Torshin I.Yu.

More about the authors

Read: 12581 times


To cite this article:

Gromova OA, Torshin IYu. Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12):69‑76. (In Russ.)
https://doi.org/10.17116/jnevro202112112169

Recommended articles:
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138
Multimodal antioxidant therapy in ischemic stroke: from MIR trial to bedside. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):64-71
Effi­cacy of combined therapy of prurigo adultorum with application of temgicoluril anxiolytic. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):210-216
Rosa­cea: from multifactorial pathogenesis to modern treatment methods. Russian Journal of Clinical Dermatology and Vene­reology. 2026;(1):23-30

References:

  1. Zhang YS, Li JD, Yan C. An update on vinpocetine: New discoveries and clinical implications. Eur J Pharmacol. 2018;819:30-34.  https://doi.org/10.1016/j.ejphar.2017.11.041
  2. Svab G, Doczi J, Gerencser AA, Ambrus A, Gallyas F, Sümegi B, Tretter L. The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria. Neurochem Res. 2019;44(10):2435-2447. https://doi.org/10.1007/s11064-019-02871-9
  3. Zhang C, Hsu CG, Mohan A, Shi H, Li D, Yan C. Vinpocetine protects against the development of experimental abdominal aortic aneurysms. ClinSci (Lond). 2020;134(22):2959-2976. https://doi.org/10.1042/CS20201057
  4. Gouliaev AH, Senning A. Piracetam and other structurally related nootropics. Brain Research. Brain Research Reviews. 1994;19(2):180-222. 
  5. Pimenov LT, Kalinina SA, Churshin AD. Clinical and hemodynamic efficacy of piracetam (nootropil) in elderly and senile patients with ischemic heart disease at the outpatient rehabilitation stage. Cardiology. 1992;5:35-38. (In Russ.).
  6. Niss AI, Umansky KG. On the effectiveness of treatment with piracetam for acute viral neuroinfections. Journal Neuropathology and Psychiatry named after S.S. Korsakov. 1985;2:189-195. (In Russ.).
  7. Pimenov LT, Churshin AD, Ezhov AV. On the ability of piracetam and tocopherol acetate to potentiate the clinical efficacy of antianginal drugs in patients with coronary heart disease. Clinical Medicine. 1997;1:32-35. (In Russ.).
  8. Avedisova AS, Akhapkin RV, Akhapkina VI, Verigo NN. Piracetam in modern research (analysis of foreign studies). Psychiatry and psychopharmacotherapy. 2000;2:6:178-184. (In Russ.).
  9. Chetly E. Stimulants of the central nervous system, Problem drugs. Per. from English. Riga, Latvia: Landmark; 1998. (In Russ.).
  10. Mashkovsky MD. Medicines. 16th ed. revised, revised and add. M.: New Wave; 2019. (In Russ.).
  11. Mikhailov IB. Clinical pharmacology. SPb.: Foliant; 1998. (In Russ.).
  12. Haress NG. Cinnarizine: Comprehensive Profile. Profiles Drug Subst Excip Relat Methodol. 2015;40:1-41. Epub 2015 Apr 1. PMID: 26051684. https://doi.org/10.1016/bs.podrm.2015.01.001
  13. Torshin IU, Gromova OA, Mayorova LA, et al. Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents. Neurology, neuropsychiatry, psychosomatics. 2021;13(2):144-156. (In Russ.). https://doi.org/10.14412/2074-2711-2021-2-144-156
  14. Gromova OA, Torshin IYu, Grishina TR, Demidov VI, Bogacheva TE. Molecular and clinical aspects of the effect of cytidine diphosphocholine on cognitive function. Journal of Neurology and Psychiatry S.S. Korsakov. 2021;121(5):81-90. (In Russ.). https://doi.org/10.17116/jnevro202112105188
  15. Gromova OA, Torshin IYu, Putilina MV, Stakhovskaya LV, Rudakov KV. Chemoreactom analysis of the central mechanisms of non-steroidal anti-inflammatory drugs. Journal of Neurology and Psychiatry S.S. Korsakov. 2020;120(1):70-77. (In Russ.). https://doi.org/10.17116/jnevro202012001170
  16. Torshin IYu, Gromova OA, Stakhovskaya LV, Semenov VA, Gromov AN. Differential chemoreactome analysis of synergistic combinations of tolperisone and nonsteroidal anti-inflammatory drugs. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2):78-85. (In Russ.). https://doi.org/10.14412/2074-2711-2019-2-78-85

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.